June 2020: Interim HealthCare Inc. introduced a free Dementia Caregiver's Guide to help family members care for a loved one with dementia or Alzheimer's disease. The Dementia Caregiver's Guide is expected provide assistance, excellent information, tools, and suggestions to the huge numbers of family members who selflessly devote their compassion, time, and resources to caring for loved ones with memory illnesses.
February 2023: Medtronic plc, received CE mark for the Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan defibrillation lead. The Aurora EV-ICD system, offers an extravascular option while keeping the conventional ICD benefits of pacing and defibrillation therapy, and is considered by patients who are at risk of experiencing life-threatening arrhythmias.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3970
Published Date: Aug 04, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing prevalence of lifestyle disorders, increasing health spending are the major factors driving the market growth.
The market size of cognitive neuroscience is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2035.
The major players in the market are Alpha Omega Inc., Laserglow Technologies, Biobserve GmbH, Medtronic Plc, Abbot Laboratories, Pear Therapeutics, Inc., Interim HealthCare Inc., Stryker Corporation, and Boston Scientific Corporation.
The neurological research segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.